<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35981059</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>02</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1935-2735</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>8</Issue><PubDate><Year>2022</Year><Month>Aug</Month></PubDate></JournalIssue><Title>PLoS neglected tropical diseases</Title><ISOAbbreviation>PLoS Negl Trop Dis</ISOAbbreviation></Journal><ArticleTitle>Chronic sequelae complicate convalescence from both dengue and acute viral respiratory illness.</ArticleTitle><Pagination><StartPage>e0010724</StartPage><MedlinePgn>e0010724</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0010724</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pntd.0010724</ELocationID><Abstract><AbstractText>Long Covid has raised awareness of the potentially disabling chronic sequelae that afflicts patients after acute viral infection. Similar syndromes of post-infectious sequelae have also been observed after other viral infections such as dengue, but their true prevalence and functional impact remain poorly defined. We prospectively enrolled 209 patients with acute dengue (n = 48; one with severe dengue) and other acute viral respiratory infections (ARI) (n = 161), and followed them up for chronic sequelae up to one year post-enrolment, prior to the onset of the Covid-19 pandemic. Baseline demographics and co-morbidities were balanced between both groups except for gender, with more males in the dengue cohort (63% vs 29%, p&lt;0.001). Except for the first visit, data on symptoms were collected remotely using a purpose-built mobile phone application. Mental health outcomes were evaluated using the validated SF-12v2 Health Survey. Almost all patients (95.8% of dengue and 94.4% of ARI patients) experienced at least one symptom of fatigue, somnolence, headache, concentration impairment or memory impairment within the first week of enrolment. Amongst patients with at least 3-months of follow-up, 18.0% in the dengue cohort and 14.6% in the ARI cohort experienced persistent symptoms. The median month-3 SF-12v2 Mental Component Summary Score was lower in patients who remained symptomatic at 3 months and beyond, compared to those whose symptoms fully resolved (47.7 vs. 56.0, p&lt;0.001), indicating that patients who self-reported persistence of symptoms also experienced functionally worse mental health. No statistically significant difference in age, gender distribution or hospitalisation status was observed between those with and without chronic sequelae. Our findings reveal an under-appreciated burden of post-infection chronic sequelae in dengue and ARI patients. They call for studies to define the pathophysiology of this condition, and determine the efficacy of both vaccines as well as antiviral drugs in preventing such sequelae.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kalimuddin</LastName><ForeName>Shirin</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-9319-5908</Identifier><AffiliationInfo><Affiliation>Department of Infectious Diseases, Singapore General Hospital, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teh</LastName><ForeName>Yii Ean</ForeName><Initials>YE</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Singapore General Hospital, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wee</LastName><ForeName>Liang En</ForeName><Initials>LE</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Singapore General Hospital, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paintal</LastName><ForeName>Shay</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Accio Systems Pte Ltd, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sasisekharan</LastName><ForeName>Ram</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Antimicrobial Resistance Interdisciplinary Research Group, Singapore-MIT Alliance for Research and Technology, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biological Engineering, Massachusetts Institute of Technology, Boston, Massachusetts, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Low</LastName><ForeName>Jenny G</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Singapore General Hospital, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Viral Research and Experimental Medicine Centre, SingHealth Duke-NUS Academic Medical Centre, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sheth</LastName><ForeName>Sujata K</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Changi General Hospital, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ooi</LastName><ForeName>Eng Eong</ForeName><Initials>EE</Initials><AffiliationInfo><Affiliation>Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Viral Research and Experimental Medicine Centre, SingHealth Duke-NUS Academic Medical Centre, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Saw Swee Hock School of Public Health, National University of Singapore, Singapore.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Negl Trop Dis</MedlineTA><NlmUniqueID>101291488</NlmUniqueID><ISSNLinking>1935-2727</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003289" MajorTopicYN="N">Convalescence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003715" MajorTopicYN="Y">Dengue</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="Y">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>18</Day><Hour>14</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>8</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35981059</ArticleId><ArticleId IdType="pmc">PMC9426910</ArticleId><ArticleId IdType="doi">10.1371/journal.pntd.0010724</ArticleId><ArticleId IdType="pii">PNTD-D-22-00645</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Michelen M, Manoharan L, Elkheir N, Cheng V, Dagens A, Hastie C, et al.. Characterising long COVID: a living systematic review. BMJ Glob Health. 2021;6(9). doi: 10.1136/bmjgh-2021-005427</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al.. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601&#x2013;15. doi: 10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi J, et al.. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185(5):881&#x2013;95.e20. doi: 10.1016/j.cell.2022.01.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirschenberger M, Hunszinger V, Sparrer KMJ. Implications of Innate Immunity in Post-Acute Sequelae of Non-Persistent Viral Infections. Cells. 2021;10(8). doi: 10.3390/cells10082134</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10082134</ArticleId><ArticleId IdType="pmc">PMC8391718</ArticleId><ArticleId IdType="pubmed">34440903</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzman MG, Gubler DJ, Izquierdo A, Martinez E, Halstead SB. Dengue infection. Nature Reviews Disease Primers. 2016;2(1):16055. doi: 10.1038/nrdp.2016.55</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2016.55</ArticleId><ArticleId IdType="pubmed">27534439</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo C, Zhou Z, Wen Z, Liu Y, Zeng C, Xiao D, et al.. Global Epidemiology of Dengue Outbreaks in 1990&#x2013;2015: A Systematic Review and Meta-Analysis. Frontiers in Cellular and Infection Microbiology. 2017;7. doi: 10.3389/fcimb.2017.00317</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2017.00317</ArticleId><ArticleId IdType="pmc">PMC5506197</ArticleId><ArticleId IdType="pubmed">28748176</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas SJ, Yoon IK. A review of Dengvaxia: development to deployment. Hum Vaccin Immunother. 2019;15(10):2295&#x2013;314. doi: 10.1080/21645515.2019.1658503</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2019.1658503</ArticleId><ArticleId IdType="pmc">PMC6816420</ArticleId><ArticleId IdType="pubmed">31589551</ArticleId></ArticleIdList></Reference><Reference><Citation>Seet RC, Quek AM, Lim EC. Post-infectious fatigue syndrome in dengue infection. J Clin Virol. 2007;38(1):1&#x2013;6. doi: 10.1016/j.jcv.2006.10.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2006.10.011</ArticleId><ArticleId IdType="pubmed">17137834</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a G, Gonz&#xe1;lez N, P&#xe9;rez AB, Sierra B, Aguirre E, Rizo D, et al.. Long-term persistence of clinical symptoms in dengue-infected persons and its association with immunological disorders. Int J Infect Dis. 2011;15(1):e38&#x2013;43. doi: 10.1016/j.ijid.2010.09.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2010.09.008</ArticleId><ArticleId IdType="pubmed">21112804</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez D, Martinez R, Castro O, Serrano T, Portela D, Vazquez S, et al.. Evaluation of Some Clinical, Humoral and Imagenological Parameters in Patients of Dengue Haemorrhagic Fever Six Months after Acute Illness. 2005.</Citation></Reference><Reference><Citation>Halsey ES, Williams M, Laguna-Torres VA, Vilcarromero S, Oca&#xf1;a V, Kochel TJ, et al.. Occurrence and correlates of symptom persistence following acute dengue fever in Peru. The American journal of tropical medicine and hygiene. 2014;90(3):449&#x2013;56. doi: 10.4269/ajtmh.13-0544</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.13-0544</ArticleId><ArticleId IdType="pmc">PMC3945690</ArticleId><ArticleId IdType="pubmed">24470564</ArticleId></ArticleIdList></Reference><Reference><Citation>Teixeira LAS, Nogueira F, Nascentes GAN. Prospective study of patients with persistent symptoms of dengue in Brazil. Rev Inst Med Trop Sao Paulo. 2017;59:e65. doi: 10.1590/S1678-9946201759065</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S1678-9946201759065</ArticleId><ArticleId IdType="pmc">PMC5587034</ArticleId><ArticleId IdType="pubmed">28876417</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigera PC, Rajapakse S, Weeratunga P, De Silva NL, Gomes L, Malavige GN, et al.. Dengue and post-infection fatigue: findings from a prospective cohort-the Colombo Dengue Study. Trans R Soc Trop Med Hyg. 2021;115(6):669&#x2013;76. doi: 10.1093/trstmh/traa110</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/trstmh/traa110</ArticleId><ArticleId IdType="pmc">PMC9115379</ArticleId><ArticleId IdType="pubmed">33099653</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiga DC, Undurraga EA, Ramos-Casta&#xf1;eda J, Mart&#xed;nez-Vega RA, Tschampl CA, Shepard DS. Persistent Symptoms of Dengue: Estimates of the Incremental Disease and Economic Burden in Mexico. The American journal of tropical medicine and hygiene. 2016;94(5):1085&#x2013;9. doi: 10.4269/ajtmh.15-0896</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.15-0896</ArticleId><ArticleId IdType="pmc">PMC4856607</ArticleId><ArticleId IdType="pubmed">26976885</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheak-Zamora NC, Wyrwich KW, McBride TD. Reliability and validity of the SF-12v2 in the medical expenditure panel survey. Qual Life Res. 2009;18(6):727&#x2013;35. doi: 10.1007/s11136-009-9483-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-009-9483-1</ArticleId><ArticleId IdType="pubmed">19424821</ArticleId></ArticleIdList></Reference><Reference><Citation>Chariyalertsak S, Wansom T, Kawichai S, Ruangyuttikarna C, Kemerer VF, Wu AW. Reliability and validity of Thai versions of the MOS-HIV and SF-12 quality of life questionnaires in people living with HIV/AIDS. Health Qual Life Outcomes. 2011;9:15. doi: 10.1186/1477-7525-9-15</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1477-7525-9-15</ArticleId><ArticleId IdType="pmc">PMC3068932</ArticleId><ArticleId IdType="pubmed">21406088</ArticleId></ArticleIdList></Reference><Reference><Citation>Cernin PA, Cresci K, Jankowski TB, Lichtenberg PA. Reliability and validity testing of the short-form health survey in a sample of community-dwelling African American older adults. J Nurs Meas. 2010;18(1):49&#x2013;59. doi: 10.1891/1061-3749.18.1.49</Citation><ArticleIdList><ArticleId IdType="doi">10.1891/1061-3749.18.1.49</ArticleId><ArticleId IdType="pubmed">20486477</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohannon RW, Maljanian R, Landes M. Test-retest reliability of short form (SF)-12 component scores of patients with stroke. Int J Rehabil Res. 2004;27(2):149&#x2013;50. doi: 10.1097/01.mrr.0000127350.25287.08</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.mrr.0000127350.25287.08</ArticleId><ArticleId IdType="pubmed">15167113</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Guidelines Approved by the Guidelines Review Committee. Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control: New Edition. Geneva: World Health Organization Copyright 2009, World Health Organization.; 2009.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Syenina A, Gan ES, Toh JZN, de Alwis R, Lin LZ, Tham CYL. Adverse effects following anti-COVID-19 vaccination with mRNA-based BNT162b2 are alleviated by altering the route of administration and correlate with baseline enrichment of T and NK cell genes. PLoS Biol. 2022;20(5):e3001643. doi: 10.1371/journal.pbio.3001643</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.3001643</ArticleId><ArticleId IdType="pmc">PMC9154185</ArticleId><ArticleId IdType="pubmed">35639676</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandarano AH, Maya J, Giloteaux L, Peterson DL, Maynard M, Gottschalk CG, et al.. Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations. J Clin Invest. 2020;130(3):1491&#x2013;505. doi: 10.1172/JCI132185</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI132185</ArticleId><ArticleId IdType="pmc">PMC7269566</ArticleId><ArticleId IdType="pubmed">31830003</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenu EW, Hardcastle SL, Atkinson GM, van Driel ML, Kreijkamp-Kaspers S, Ashton KJ, et al.. Natural killer cells in patients with severe chronic fatigue syndrome. Auto Immun Highlights. 2013;4(3):69&#x2013;80. doi: 10.1007/s13317-013-0051-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13317-013-0051-x</ArticleId><ArticleId IdType="pmc">PMC4389023</ArticleId><ArticleId IdType="pubmed">26000145</ArticleId></ArticleIdList></Reference><Reference><Citation>Klimas NG, Salvato FR, Morgan R, Fletcher MA. Immunologic abnormalities in chronic fatigue syndrome. Journal of clinical microbiology. 1990;28(6):1403&#x2013;10. doi: 10.1128/jcm.28.6.1403-1410.1990</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jcm.28.6.1403-1410.1990</ArticleId><ArticleId IdType="pmc">PMC267940</ArticleId><ArticleId IdType="pubmed">2166084</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long covid-mechanisms, risk factors, and management. BMJ (Clinical research ed). 2021;374:n1648. doi: 10.1136/bmj.n1648</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Number of smartphone subscritpions wordlwide from 2016 to 2027 [Available from: https://www.statista.com/statistics/330695/number-of-smartphone-users-worldwide/.</Citation></Reference><Reference><Citation>Vyas S, Ray N, Maralakunte M, Kumar A, Singh P, Modi M, et al.. Pattern Recognition Approach to Brain MRI Findings in Patients with Dengue Fever with Neurological Complications. Neurol India. 2020;68(5):1038&#x2013;47. doi: 10.4103/0028-3886.294556</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0028-3886.294556</ArticleId><ArticleId IdType="pubmed">33109849</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>